Diarrhea News and Research

Latest Diarrhea News and Research

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.

7 May 2011

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

7 May 2011

H. pylori DNA may help treat severe colitis

DNA from Helicobacter pylori, a common stomach bacteria, minimizes the effects of colitis in mice, according to a new study by University of Michigan Medical School scientists.

6 May 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.

6 May 2011

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile Universal Direct test on the 3M Integrated Cycler.

From Quest Diagnostics 6 May 2011

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin in patients with unresectable, locally advanced or metastatic disease.

6 May 2011

Fecal transplant procedures performed at Sinai Hospital

Sudhir Dutta, M.D., head of the Division of Gastroenterology at Sinai Hospital, performed fecal transplant procedures for two patients with severe clostridium difficile (C. difficile) colitis that did not respond to routine antibiotic and other treatments. C. difficile causes symptoms ranging from mild diarrhea to more serious, sometimes life threatening colon inflammation.

5 May 2011

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation, the most common form of cardiac arrhythmia.

5 May 2011

Childhood cancer survivors may face high risk of late GI complications after therapy

Patients who received therapy for cancer during childhood have an increased risk of developing gastrointestinal complications later in life, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

5 May 2011

iOWH, Center for World Health and Medicine partner to combat childhood diarrhea

The Center for World Health and Medicine at Saint Louis University and the Institute for OneWorld Health have established a joint research agreement to develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5.

4 May 2011

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

Santarus, Inc. today announced that the budesonide MMX Phase III clinical program will be featured in two oral presentations at the Digestive Disease Week Meeting being held at McCormick Place in Chicago on May 7-10, 2011.

3 May 2011

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.

3 May 2011

Study explores link between infants' daily growth and sleep

Science is finally confirming what grandma knew all along: infants wake up taller right after they sleep.

2 May 2011

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.

30 Apr 2011

Penn Nursing, Surgeon General partner to promote breastfeeding awareness in the U.S.

While 75 percent of U.S. babies start out breastfeeding, the U.S. Centers for Disease Control and Prevention reports only 13 percent are exclusively breastfed at the end of six months. Six months of exclusive breastfeeding is the American Academy of Pediatrics' minimum recommendation.

30 Apr 2011

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.

30 Apr 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Affymax, Inc. and Takeda Pharmaceutical Company Limited, today announced results of additional analyses from two Phase 3 studies of the investigational agent, peginesatide in chronic renal failure patients on dialysis with anemia.

29 Apr 2011

Food poisoning costs the United States billions: Report

According to a new report published Thursday, 14 different pathogens causing food poisoning cost the United States $14 billion annually in terms of human disease. The report comes from the University of Florida Emerging Pathogens Institute that found that out of all the pathogen-food combinations they studied, campylobacter in poultry was the single worst offender, causing more than 600,000 illnesses per year, hospitalizing more than 7,000 people and costing, annually, $1.3 billion and 9,500 quality-of-life years.

29 Apr 2011

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.

28 Apr 2011

Diarrhea News and Research

Latest Diarrhea News and Research

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

H. pylori DNA may help treat severe colitis

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Fecal transplant procedures performed at Sinai Hospital

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Childhood cancer survivors may face high risk of late GI complications after therapy

iOWH, Center for World Health and Medicine partner to combat childhood diarrhea

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

Study explores link between infants' daily growth and sleep

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Penn Nursing, Surgeon General partner to promote breastfeeding awareness in the U.S.

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Food poisoning costs the United States billions: Report

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diarrhea News and Research

Latest Diarrhea News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in